Skip to content

Analysis of correlation between gut microbiota and POD after cardiopulmonary bypass in elderly patients

The effect of gut microbiota on PND induced by cardiopulmonary bypass by regulating enteric glial cell

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034815
Enrollment
Unknown
Registered
2020-07-20
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive disorders

Interventions

postoperative delirium group:Nil

Sponsors

The General Hospital of Northen Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: NP group 1. Aged 18 years- 45 years ; 2. Subjects with BMI of 17.5-30.0kg/m2; 3. Those with education level >= junior high school; 4. Basic cognitive function was normal (MMSE score >= 27 and MOCA score >= 26); 5. Subjects without anxiety and depression (SAS / SDS score = 27 and MOCA score >= 26); 7. Patients without anxiety and depression (SAS / SDS score < 53); 8. Patients with postoperative delirium.

Exclusion criteria

Exclusion criteria: NP group 1. The object of rejection; 2. Subjects with a history of cognitive dysfunction; 3. Subjects with previous neurological and mental disorders; 4. Long term use of psychotropic drugs or continuous use of antibiotics for more than 3 days in recent 3 months; 5. Subjects with a history of stroke or other organic encephalopathy; 6. Those who are or have suffered from malignant tumor; 7. Patients with intestinal system function or organic diseases, such as irritable bowel syndrome, ulcerative colitis, etc. Group P: 1. The patient refused; 2. Patients who have been taking psychotropic drugs for a long time or taking antibiotics for more than 3 days in recent 3 months; 3. Patients with preoperative anxiety or delirium history; 4. Patients with previous neurological and mental disorders; 5. Patients with a history of stroke or other organic encephalopathy; 6. Patients who are or have been suffering from malignant tumor; 7. Patients with abnormal thyroid function, liver and kidney function; 8. Patients with intestinal system function or organic diseases, such as irritable bowel syndrome, ulcerative colitis, etc; 9. Patients with more blood loss (> 500ml) or receiving blood transfusion during operation; 10. Patients with hypoxemia (SpO2 < 90%) during perioperative period.

Design outcomes

Primary

MeasureTime frame
Cognitive function score;Metagenomic sequencing of fecal flora;

Countries

China

Contacts

Public ContactSun Yingjie

North theater General Hospital

sunyingjie9@hotmail.com+86 13940348767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026